Inhye Ahn
Clinical trials sponsored by Inhye Ahn, explained in plain language.
-
New combo aims to erase last traces of leukemia
Disease control Recruiting nowThis study tests whether the drug mosunetuzumab, given alone or with a BTK inhibitor, can clear tiny amounts of leftover leukemia cells in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). About 40 adults who are already on or have recently finis…
Phase: PHASE1, PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated May 26, 2026 04:09 UTC
-
New hope for CLL patients: One-Year drug combo aims to control disease
Disease control Recruiting nowThis study is for people with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. It tests a one-year treatment with two drugs, pirtobrutinib and obinutuzumab, to see how well they control the disease. About 60 participants will receive the therapy for 12 cycles…
Phase: PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated May 22, 2026 14:01 UTC